Moftakhar, Bahar https://orcid.org/0000-0003-0860-0441
Lekkala, Manidhar
Strawderman, Myla
Smith, Tae C.
Meacham, Philip
Fitzgerald, Bryan
Falkson, Carla I.
Dhakal, Ajay
Article History
Received: 23 April 2020
Accepted: 7 July 2020
First Online: 15 July 2020
Compliance with ethical standards
:
: Dr. Moftakhar declares that she has no conflict of interest. Dr. Lekkala has stocks in Pfizer, Editas, AbbVie, Atara, Teva, and Mylan. Ms. Strawderman declares that she has no conflict of interest. Dr. Smith declares that she has no conflict of interest. Dr. Meacham declares that he has no conflict of interest. Dr. Fitzgerald declares that he has no conflict of interest. Dr. Falkson has received research funding from Roche, Genentech, Novartis, Seattle Genetics, Pfizer, and Lily at her prior institution. Dr. Dhakal has received an honorarium from Daichii Sankyo.
: This research study was conducted retrospectively from data obtained for clinical purposes. We consulted extensively with the IRB of the University of Rochester who determined that our study did not need ethical approval.